Almirall in Numbers. Our devotion to science and people can be measured +100 Countries where we help patients +2,027 Employees (54% women) 14 Affiliates Present within Europe and US. €124,2 MM Organic R&D and in-licensing payments. €985.7 MM Net Sales. Our suppliers, key to deploy our Purpose.

Almirall is a leading skin-health focused global pharmaceutical company based in Barcelona that partners with healthcare professionals, applying Science to provide medical solutions to patients and future generations.

Almirall products by country. Check which Almirall products are available in your country by selecting from the list below

Almirall is committed to working with you on a basis of respect and integrity. We understand there are many people affected by what we do, including patients, healthcare professionals, our partners, peers and other stakeholders. Learn more about our commitments

November 17 th, 2023 – Almirall S.A. (BME: ALM), a global biopharmaceutical company focused on medical dermatology, announced today that the European Commission (EC) has approved EBGLYSS (lebrikizumab) for the treatment of adult and adolescent patients (12 years and older with a body weight of at least 40 kg) with moderate-to-severe atopic ...

2025年1月14日 · Almirall, S.A. (ALM) San Francisco 14th January 2025 Almirall, a global pharmaceutical company dedicated to medical dermatology, is participating in the 2025 JPMorgan HealthCare Conference to provide an update on its business strategy and outlook.

2024年9月25日 · Almirall has the exclusive rights to develop and commercialize lebrikizumab for the treatment of dermatology indications, including eczema, in Europe. Almirall's partner Lilly has the rights for development and commercialization of this biologic in the U.S. and the rest of the world outside Europe. About ADjoin

Several criteria are used to classify the different types of skin.For example, Fitzpatrick's classification, first described in 1975, is based on skin color and its response to sun exposure. It is used to determine the proper type of sun protection factor or to predict the risk of skin cancer, among others.However, from a cosmetic point of view, skin is …

Zgodnie z Kodeksem Dobrych Praktyk Europejskiej Federacji Przemysłu i Stowarzyszeń Farmaceutycznych (EFPIA), a także przepisami krajowymi, firma Almirall udostępnia informacje dotyczące udzielanego przez nią wsparcia na rzecz organizacji pacjentów.

In Almirall we explain you the different treatments to face Atopic Dermatitis in children and adults. Discover them here!